CAS: 1401966-69-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK2879552 REF: IN-DA009CI4CAS: 1401966-69-5 | 98% | To inquire | Tue 10 Dec 24 |
 | GSK2879552 REF: TM-T3677CAS: 1401966-69-5 | 99.22% | 36.00 €~106.00 € | Fri 13 Dec 24 |
 | GSK2879552 REF: 3D-BG170574CAS: 1401966-69-5 | Min. 95% | To inquire | Tue 21 Jan 25 |
GSK2879552
CAS:1401966-69-5
Formula:
C23H28N2O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
364.4806
Ref: IN-DA009CI4
| 5mg | 153.00 € | ||
| 10mg | 281.00 € | ||
| 25mg | 528.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
GSK2879552
CAS:1401966-69-5
GSK2879552: oral, irreversible LSD1 inhibitor with potential cancer-fighting properties.
Formula:
C23H28N2O2
Purity:
99.22%
Color and Shape:
Solid
Molecular weight:
364.48
Ref: TM-T3677
| 2mg | 106.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
GSK2879552
CAS:1401966-69-5
GSK2879552 is a chemical compound that inhibits the transcriptional activation of genes. It is a …
Purity:
Min. 95%
Ref: 3D-BG170574
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
